At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> SEC Filings

SEC Filings

  
Filing Description Date Filed Sorted Descending Size View  
4 valenzano, ken Jun 24, 2015 29.1 KB View HTML View PDF View XLS  
4 castelli, jeff Jun 24, 2015 27.5 KB View HTML View PDF View XLS  
4 hayden, donald j jr Jun 24, 2015 28.2 KB View HTML View PDF View XLS  
4 dilone, enrique Jun 23, 2015 29.1 KB View HTML View PDF View XLS  
4 campbell, bradley l Jun 23, 2015 27.5 KB View HTML View PDF View XLS  
4 baird, william d iii Jun 23, 2015 28.3 KB View HTML View PDF View XLS  
4 yu, julie Jun 16, 2015 24.5 KB View HTML View PDF View XLS  
4 castelli, jeff Jun 16, 2015 24.4 KB View HTML View PDF View XLS  
4 hayden, donald j jr Jun 12, 2015 23.9 KB View HTML View PDF View XLS  
4 sblendorio, glenn Jun 12, 2015 23.9 KB View HTML View PDF View XLS  
4 raab, michael Jun 12, 2015 23.8 KB View HTML View PDF View XLS  
4 mcglynn, margaret g Jun 12, 2015 22.7 KB View HTML View PDF View XLS  
4 love, ted w Jun 12, 2015 23.8 KB View HTML View PDF View XLS  
4 essner, robert Jun 12, 2015 23.8 KB View HTML View PDF View XLS  
4 barer, sol j Jun 12, 2015 23.8 KB View HTML View PDF View XLS  
8-K current report Jun 12, 2015 303.2 KB View HTML View PDF View XLS  
424B5 prospectus filed pursuant to rule 424 Jun 12, 2015 324.3 KB View HTML View PDF View XLS  
FWP free writing prospectus - filing under securities act rules 163/433 Jun 12, 2015 26.9 KB View HTML View PDF  
S-3MEF registration statement Jun 11, 2015 85.0 KB View HTML View PDF View XLS  
424B5 prospectus filed pursuant to rule 424 Jun 10, 2015 323.6 KB View HTML View PDF View XLS  
Showing 1-20 of 924 Page: 1 2 3 4 5 ... 47  Next 20

Copyright © 2015 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy